Return of disease activity after natalizumab therapy discontinuation in patients with multiple sclerosis: frequency and clinical and instrumental predictors of reactivation
- Autori: Realmuto, S; Salemi, G; Ragonese, P; Lo Re, M; Lo Re, V; Mazzola, M; Savettieri, G
- Anno di pubblicazione: 2012
- Tipologia: eedings
- OA Link: http://hdl.handle.net/10447/72820